Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy clinical trials

Explore recruiting sub study 5 unresectable pleural mesothelioma volrustomig monotherapy clinical trials.

Recruiting sub study 5 unresectable pleural mesothelioma volrustomig monotherapy studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Volrustomig as Monotherapy or in Combination with Anti-cancer Agents in Participants with Advanced/Metastatic Solid Tumors (eVOLVE-02)

Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy trials by city

Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Toronto Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Vancouver Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Montreal Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Calgary Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Edmonton Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Ottawa Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Winnipeg Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Quebec City Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Hamilton Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Kitchener Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in London Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Halifax Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in New York Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Los Angeles Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Chicago Sub Study 5 Unresectable Pleural Mesothelioma Volrustomig Monotherapy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease